Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Polard

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 9, 2017
Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists-a nationwide population-based cohort study based on 2010-2013 French Health Insurance dataLucie-Marie Scailteux, Sébastien Vincendeau, Frédéric Balusson, et al.
Therapie|December 30, 2020
[Adverse drug reactions profiles for abiraterone and enzalutamide: A pharmacovigilance descriptive analysis]Lucie-Marie Scailteux, Clémence Lacroix, Sandrine Bergeron, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2025
Cefepime Concentration-Toxicity Relationship in Hematological Patients Treated With Continuous Infusion: A Prospective StudySébastien Lalanne, Marie-Noëlle Osmont, Louise Triquet, et al.
Infectious Diseases Now|December 8, 2025
Seasonal influenza and pneumococcal vaccination coverage among immunocompromised adults in France: A need for improvementMarine Cailleaux, Frédéric Balusson, Fabienne Pelé, et al.
Cardiovascular Drugs and Therapy|February 17, 2021
Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19Laurent Chouchana, Nathanaël Beeker, Nicolas Garcelon, et al.
British Journal of Clinical Pharmacology|June 3, 2020
Hospital databases for the identification of adverse drug reactions: A 2-year multicentre study in 9 French general hospitalsMarie-Noëlle Osmont, Adeline Degremont, Hélène Jantzem, et al.
Cardiovascular Drugs and Therapy|March 4, 2021
Correction to: Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19Laurent Chouchana, Nathanaël Beeker, Nicolas Garcelon, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 22, 2023
Osteonecrosis of the jaw under palbociclib: A case series descriptionChabnam Yosofi, Sophie Cairon-Lejeune, Claudia Lefeuvre-Plesse, et al.
Epilepsy & Behavior : E&B|November 28, 2021
Impact of recommendations on sodium valproate prescription among women with epilepsy: An interrupted time-series studyAdeline Degremont, Elisabeth Polard, Sandrine Kerbrat, et al.
Fundamental & Clinical Pharmacology|July 1, 2020
Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatmentsFlorian Lemaitre, Caroline Solas, Matthieu Grégoire, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
European Journal of Cancer (Oxford, England : 1990)|April 9, 2017
Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists-a nationwide population-based cohort study based on 2010-2013 French Health Insurance dataLucie-Marie Scailteux, Sébastien Vincendeau, Frédéric Balusson, et al.
Therapie|December 30, 2020
[Adverse drug reactions profiles for abiraterone and enzalutamide: A pharmacovigilance descriptive analysis]Lucie-Marie Scailteux, Clémence Lacroix, Sandrine Bergeron, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2025
Cefepime Concentration-Toxicity Relationship in Hematological Patients Treated With Continuous Infusion: A Prospective StudySébastien Lalanne, Marie-Noëlle Osmont, Louise Triquet, et al.
Infectious Diseases Now|December 8, 2025
Seasonal influenza and pneumococcal vaccination coverage among immunocompromised adults in France: A need for improvementMarine Cailleaux, Frédéric Balusson, Fabienne Pelé, et al.
Cardiovascular Drugs and Therapy|February 17, 2021
Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19Laurent Chouchana, Nathanaël Beeker, Nicolas Garcelon, et al.
British Journal of Clinical Pharmacology|June 3, 2020
Hospital databases for the identification of adverse drug reactions: A 2-year multicentre study in 9 French general hospitalsMarie-Noëlle Osmont, Adeline Degremont, Hélène Jantzem, et al.
Cardiovascular Drugs and Therapy|March 4, 2021
Correction to: Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19Laurent Chouchana, Nathanaël Beeker, Nicolas Garcelon, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 22, 2023
Osteonecrosis of the jaw under palbociclib: A case series descriptionChabnam Yosofi, Sophie Cairon-Lejeune, Claudia Lefeuvre-Plesse, et al.
Epilepsy & Behavior : E&B|November 28, 2021
Impact of recommendations on sodium valproate prescription among women with epilepsy: An interrupted time-series studyAdeline Degremont, Elisabeth Polard, Sandrine Kerbrat, et al.
Fundamental & Clinical Pharmacology|July 1, 2020
Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatmentsFlorian Lemaitre, Caroline Solas, Matthieu Grégoire, et al.
Pageof 7